Showing results (1-10 of 497) with videos related to
Sort By:
Pageof 50
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 18, 2008
[Trastuzumab and Fcgamma]Hiroyasu Yamashiro, Masakazu ToiGan to Kagaku Ryoho. Cancer & Chemotherapy|July 22, 2009
[Anti-HER2 antibody and small-molecule tyrosine kinase inhibitor therapy targeting EGFR signal pathway]Hiroyasu Yamashiro, Masakazu ToiGan to Kagaku Ryoho. Cancer & Chemotherapy|August 10, 2007
[Herceptin (trastuzumab)]Hiroyasu Yamashiro, Masakazu ToiNihon Rinsho. Japanese Journal of Clinical Medicine|October 20, 2010
[Molecular targeted therapy for breast cancer treatment, challenge to cure]Hiroyasu Yamashiro, Masakazu ToiInternational Journal of Clinical Oncology|March 1, 2008
Update of evidence in chemotherapy for breast cancerHiroyasu Yamashiro, Masakazu ToiBreast Cancer (Tokyo, Japan)|March 5, 2009
Risk reduction of distant metastasis in hormone-sensitive postmenopausal breast cancerMasakazu Toi, Hiroyasu Yamashiro, Wakako TsujiNihon Rinsho. Japanese Journal of Clinical Medicine|July 31, 2004
[Trastuzumab treatment for breast cancer]Hiroyasu Yamashiro, Kazumi Toyama, Hiroko Bando, et al.Journal of Tissue Engineering and Regenerative Medicine|October 16, 2009
In situ adipogenesis in fat tissue augmented by collagen scaffold with gelatin microspheres containing basic fibroblast growth factorYu Kimura, Wakako Tsuji, Hiroyasu Yamashiro, et al.Breast Cancer (Tokyo, Japan)|January 14, 2004
Current status of antibody therapy for breast cancerMasakazu Toi, Masahiro Takada, Hiroko Bando, et al.Breast Cancer : Basic and Clinical Research|February 9, 2019
Clinical Predictive Factors for the Efficacy of Everolimus in Patients With Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer: A Multicenter Retrospective Cohort Study in JapanYuichiro Kikawa, Takeshi Kotake, Yukiko Kajiwara, et al.Pageof 50